It Takes Two to Tango: Combining Epigenetic Therapy and Immunotherapy
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
Category: Journals
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
Two studies published today in the AACR's journal Cancer Research describe developing CAR T cells to make them safe...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
While most of the United States has experienced large declines in colorectal cancer death rates in recent years, progress...
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and...